Original articles: General thoracic
Thoracoscopic thymectomy in autoimmune myasthenia: results of left-sided approach

https://doi.org/10.1016/S0003-4975(00)01237-6Get rights and content

Abstract

Background. We undertook to analyze the results of video-assisted thoracoscopic thymectomy through a left-sided approach in patients with autoimmune myasthenia.

Methods. Between 1993 and 1997, 31 patients underwent thoracoscopic thymectomy by a uniform left-sided approach. There were 8 men and 23 women with a mean age of 34 ± 12 years.

Results. Preoperative duration of disease was 14.8 ± 11 months. There were no operative deaths or major complications. The mean hospital stay was 5.2 ± 2.8 days. Mean follow-up was 39.6 ± 15 months and was 100% complete. At 48 months, remission and improvement rates were 36% and 96%, respectively. Shorter duration of symptoms (< 12 months) correlated with improved outcome (13 of 13 patients versus 10 of 14 patients; p = 0.036). Age, sex, Osserman class, corticosteroid therapy, presence of ectopic thymic tissue, and temporary postoperative symptom increase (deterioration) did not affect outcome.

Conclusions. Thoracoscopic thymectomy facilitated the goal of early thymectomy. Through a left-sided approach, improvement or remission was achieved in more than 95% of the patients. Thoracoscopic thymectomy should be considered a valid less invasive alternative to the most radical open approaches.

Section snippets

Material and methods

Between January 1993 and December 1997, 31 patients (8 men and 23 women) with autoimmune myasthenia (AM) underwent VATS thymectomy at two participating institutions (Tor Vergata University in Rome, Italy, and Catholic University in Leuven, Belgium). The thoracic surgeons at each institution had gained experience with various major thoracoscopic procedures before embarking on the study. Informed consent was obtained from all patients, who were given the basic information on the different

Results

Patient age ranged from 20 to 69 years with a mean of 34 ± 12 years. The preoperative mean Osserman class was 2.16 ± 0.7; 6 patients were in class 1, 13 in class 2, 10 in class 3, and 2 in class 4. The duration of symptoms ranged from 1 month to 46 months with a mean of 14.8 ± 11 months. Preoperatively, pyridostigmine bromide alone was used in 23 patients (74%), and corticosteroids were used in 8 patients (26%), either alone (1 patient) or in association with pyridostigmine (7 patients).

Comment

Video-assisted thoracoscopic surgery has provided a new approach for the surgical removal of the thymus. Proponents of VATS thymectomy believe that it combines the minimal surgical trauma of the transcervical approach and the excellent visualization of the anterior mediastinum of the transsternal approach. Also, VATS does not prevent easy access to the lower cervical area, thereby allowing complete removal of the superior thymic horns 8, 9, 10, 11. Recognized advantages of VATS over open

Cited by (117)

  • Approach to the Mediastinum: Transcervical, Transsternal, and Video-Assisted

    2021, Surgery of the Thyroid and Parathyroid Glands
  • Video-assisted thoracoscopic surgery for myasthenia gravis with thymoma: A six-year single-center experience

    2021, Asian Journal of Surgery
    Citation Excerpt :

    The majority of patients in our study were extubated after surgery within 48 h (68.9%). Nonetheless, our postoperative hospital stay was 9.8 ± 5.9 days (5–37 days) with 45.9% less than 7 days, which is however still longer than results from other authors, ranging from 2.28 to 5 days.14,22,23,16 Favorable outcomes after thymectomy for MG with thymoma have been reported with VATS.

  • Robotic thymectomy: a review of techniques and results

    2023, Kardiochirurgia i Torakochirurgia Polska
View all citing articles on Scopus
View full text